Several other research analysts have also issued reports on DHR. BTIG Research reiterated a buy rating and set a $92.00 price objective on shares of Danaher Corporation in a research note on Sunday, April 23rd. Zacks Investment Research lowered Danaher Corporation from a buy rating to a hold rating in a research note on Friday, April 21st. BidaskClub upgraded Danaher Corporation from a sell rating to a hold rating in a research note on Wednesday, June 21st. Royal Bank Of Canada restated a sector perform rating and issued a $88.00 target price (down from $89.00) on shares of Danaher Corporation in a research note on Friday, April 21st. Finally, Deutsche Bank AG restated a buy rating and issued a $97.00 target price on shares of Danaher Corporation in a research note on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $91.76.
Danaher Corporation (NYSE:DHR) traded down 0.05% during mid-day trading on Friday, hitting $80.87. 2,861,306 shares of the stock traded hands. The stock has a 50-day moving average of $82.32 and a 200 day moving average of $84.22. The firm has a market cap of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the company posted $0.90 earnings per share. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities analysts expect that Danaher Corporation will post $3.95 EPS for the current year.
In other news, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock worth $3,206,426 in the last quarter. 12.20% of the stock is currently owned by company insiders.
A number of large investors have recently made changes to their positions in the stock. Quadrature Capital Ltd purchased a new stake in shares of Danaher Corporation during the fourth quarter worth about $9,980,000. Ibex Wealth Advisors purchased a new stake in shares of Danaher Corporation during the fourth quarter worth about $355,000. Perigon Wealth Management LLC purchased a new stake in shares of Danaher Corporation during the fourth quarter worth about $279,000. USA Financial Portformulas Corp raised its stake in shares of Danaher Corporation by 9.5% in the fourth quarter. USA Financial Portformulas Corp now owns 35,170 shares of the conglomerate’s stock worth $2,738,000 after buying an additional 3,042 shares in the last quarter. Finally, HighPoint Advisor Group LLC purchased a new stake in shares of Danaher Corporation during the fourth quarter worth about $226,000. 76.12% of the stock is currently owned by institutional investors and hedge funds.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.